Source: Health Canada shortage reports · Updated Jul 15, 2026
Some Candesartan Cilexetil products are in shortage in Canada (21 of 59 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 14, 2026.
An angiotensin receptor blocker used to lower blood pressure and treat heart failure.
Products affected
21 / 59
In shortage since
Sep 15, 2016
Est. full return
Aug 14, 2026
Reports on file
270
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TARO-CANDESARTAN
4MG · TABLET · SUN PHARMA CANADA INC
DIN 02380684 · since Jun 11, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
8MG · TABLET · APOTEX INC
DIN 02541297 · since Apr 28, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
16MG · TABLET · APOTEX INC
DIN 02541300 · since Apr 21, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
8MG · TABLET · APOTEX INC
DIN 02541297 · since Mar 24, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
4MG · TABLET · APOTEX INC
DIN 02541289 · since Aug 19, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
4MG · TABLET · APOTEX INC
DIN 02541289 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
32MG · TABLET · APOTEX INC
DIN 02541319 · since Feb 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
16MG · TABLET · APOTEX INC
DIN 02541300 · since Feb 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-CANDESARTAN
8MG · TABLET · ACCORD HEALTHCARE INC
DIN 02379279 · since Dec 6, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
CANDESARTAN
8MG · TABLET · SANIS HEALTH INC
DIN 02388928 · since Aug 23, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CANDESARTAN
32MG · TABLET · SANIS HEALTH INC
DIN 02435845 · since Aug 30, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CANDESARTAN
16MG · TABLET · SANIS HEALTH INC
DIN 02388936 · since Sep 9, 2024, no end estimate · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Candesartan Cilexetil is currently affected by 21 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, APOTEX INC, ACCORD HEALTHCARE INC, SANIS HEALTH INC and 2 others.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; demand increase for the drug; health canada has imposed a new restriction for candesartan finished product; health canada has imposed a new restriction for candesartan finished product. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Candesartan Cilexetil is classified under “ANGIOTENSIN II ANTAGONISTS, PLAIN” (ATC C09CA).
Recent changes
Jul 15, 2026
New report filed
Common questions
What is Candesartan Cilexetil used for?
An angiotensin receptor blocker used to lower blood pressure and treat heart failure.
When will Candesartan Cilexetil be back in stock in Canada?
The latest manufacturer estimate is Aug 14, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Candesartan Cilexetil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.